Nachrichten zur Akebia Therapeutics Inc. Aktie

Recap: Akebia Therapeutics Q1 Earnings

Shares of Akebia Therapeutics (NASDAQ:AKBA) surged 24% after the company reported Q1 results. Quarterly Results Earnings per share fell 6.82% year over…

Akebia Therapeutics, Inc. 2020 Q1 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia up 25% premarket on positive vadadustat data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebias shares jump on late-stage clinical trial results for kidney disease drug

Shares of Akebia Therapeutics Inc. gained 30% in premarket trading on Tuesday after the drugmaker reported positive topline results…

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass. , May 4, 2020 /PRNewswire/ --  Akebia Therapeutics …

2 Small-Cap Stocks That Could Double Your Money

Akebia Therapeutics and Satsuma Pharmaceuticals could both be big winners for early shareholders....…

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass. , April 2, 2020 /PRNewswire/ --  Akebia Therapeutics …

Is the Options Market Predicting a Spike in Akebia Therapeutics (AKBA) Stock-

Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately....…

Akebia files to offer up to $65M in stock

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Akebia Therapeutics Stock Sank Today

The biotech provided a disappointing Q4 update....…

Akebia Therapeutics Inc (AKBA) Q4 2019 Earnings Call Transcript

AKBA earnings call for the period ending December 31, 2019....…

Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q4 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics (AKBA) Reports Q4 Loss, Misses Revenue Estimates

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -35.56% and -27.09%, respectively, for the quarter ended December 2019. Do…

Will Akebia Therapeutics (AKBA) Report Negative Earnings Next Week- What You Should Know

Akebia Therapeutics (AKBA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

Is the Options Market Predicting a Spike in Akebia Therapeutics (AKBA) Stock-

Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately....…

Stock To Watch: Will 2020 Be A Defining Year For Akebia (AKBA)-

Shares of Akebia Therapeutics Inc. (AKBA), which touched a new 52-week high of $10.42 in intraday trading yesterday, have gained…